Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 5/100

Failure Rate

0.0%

0 terminated/withdrawn out of 5 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

60%

3 trials in Phase 3/4

Results Transparency

75%

3 of 4 completed trials have results

Key Signals

3 with results

Enrollment Performance

Analytics

Phase 4

2(50.0%)

Phase 1

1(25.0%)

Phase 3

1(25.0%)

4Total

Phase 4(2)

Phase 1(1)

Phase 3(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials

NCT05612399Not Yet Recruiting

Precision Analgesia for Cardiac Surgery

Role: lead

NCT03569085Phase 1Completed

Inhaled Anesthetics and Myocardial Strain

Role: lead

NCT03270514Phase 3Completed

Comparison of Sternal Wound Infiltration With Liposomal Bupivacaine v. Bupivacaine Hydrochloride

Role: lead

NCT03198871Phase 4Completed

IV Acetaminophen for Post-Operative Pain Management in Enhanced Recovery After Surgery (ERAS) Population

Role: lead

NCT02349152Phase 4Completed

Remifentanil and Glycemic Response in Cardiac Surgery

Role: lead

All 5 trials loaded